Navigation Links
GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World Leader in Sirtuin Research and Development
Date:6/6/2008

LONDON, PHILADELPHIA and CAMBRIDGE, Mass., June 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that it has completed its acquisition of Sirtris Pharmaceuticals, Inc. (Sirtris) for approximately USD720 million (or approx. GBP362 million) through a cash tender offer and merger of USD22.50 (or approx. GBP11.33) per share.

Through the acquisition of Sirtris, GSK has significantly enhanced its metabolic, neurology, immunology and inflammation research efforts by establishing a presence in the field of sirtuins, a recently discovered class of enzymes that is believed to be involved in the ageing process.

Sirtris will become part of GSK's Drug Discovery organization, while continuing to operate from laboratories in Cambridge, Massachusetts, as an autonomous drug discovery unit. Christoph Westphal, CEO and Vice Chair of Sirtris, and the management team will continue to lead this autonomous unit.

About GSK

GSK -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information including a copy of this announcement and details of the company's updated product development pipeline, visit GSK at http://www.gsk.com.


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
9. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
10. GlaxoSmithKline Presents Innovative Neuroscience Pipeline
11. GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... Benton Communications announces a h... system for retailers struggling to make an econom...vember 26, 2009 -- Flu fears is the type of challe...ergency room, according to Dr. David Benton, busin... business growth system – The Rfactor Inten...
(Date:11/25/2009)...SASCITY,Mo.,Nov.25/PRNewswire/--TheBartleHallConve...medicalcliniconDec.9-10,whenKansasCityhoststhelate... ,, "Thisfreecliniceventhasthepotentialtobetheb...ofjustoneandbeheldonweekdaysinsteadofoveraweekend,...lthClinicandpresidentoftheNationalAssociationofFre...
(Date:11/25/2009)...ONTO,Nov.25/PRNewswire/-SentinelleMedicalInc.,alea...zationsoftwarelaunchesasuiteofnewleadingedgeclinic...platformatthisyear,sRadiologicalSocietyofNorthAmer...Booth5800,HallA).Theapplicationsleveragetheuniqueh...MRIimagingcoilsandsupportmultipleimagingmodalities...
(Date:11/25/2009)...ANGELES,Nov.25/PRNewswire-USNewswire/--TheBlackAID...termineexecutiveleadershipfor2010. ,, ThenewBoa...ltiesinpublicpolicy,law,finance,governmenthealthpr...ardalsocomesfromawiderangeofpersonalbackgroundsinc...ivingwithHIVthemselves,andrepresentingmultipleageg...
(Date:11/25/2009)... survivors of testicular cancer who were treated w...ide effects, including neurological side effects a...reated with chemotherapy, according to a new study...he National Cancer Institute . , Marianne Brydy,...iversity Hospital, in Bergen, Norway, and colleagu...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...w scientists are confirming in laboratory studies ...duct collected from beehives--may inhibit the deve...ity of Campinas, Brazil, found that propolis// con...ucrose and promote the binding of cariogenic bacte...
...cording to researchers a new has been found way of... into cartilage that could be used to repair knee ...al of tissue engineering where replacement// or re...pmental pathways - to become more specialised. ...
...ur people are confirmed dead from pneumonic plague... of the plague from a remote village of Himachal P...ptoms of pneumonic plague. // "The sequence o...C.P. Thakur said. "The good news is that the disea...
...male circumcision, or mutilation of the genitals ..., the Middle East and large areas of Africa. Parti...nd religious reasons, but rivals// say that not on...of the tip of the clitoris; Total removal of the c...
...cording to doctors at the research center the radi...sarcoma is an unusual tumour of the bone which is ...r, one case in ten proves resistant to these thera... other treatments and had multiple bone cancer sit...
.... Reddy's Laboratories (DRL) has been slapped with... AAI Pharma Inc for the generic version of the ant...sivity to sell the drug's 40 mg dosage form along ... the patent expiry allows the patent holder to fil...
Other Medicine News:
(Date:11/25/2009)....,Nov.25/PRNewswire-FirstCall/--HeskaCorporation(H...ticandspecialtyproductstotheveterinaryindustry,ann...onforthesupplyofbloodgasproductsandaffiliatedconsu...www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ...nginthefieldofadvancedpoint-of-carediagnostics,"co...
(Date:11/25/2009)....25/PRNewswire/--BioTrendsResearchGroup,Inc.releas...,thefirstinamulti-phasesyndicatedmarketresearchpro...ara,fromproductlaunchthroughthefirstsixmonthsofava...nformationfrom75uniqueDermatologistsandqualitative...duseofStelara,obstaclestouse,typicalpatienttypes,p...
(Date:11/25/2009)...N.J.,Nov.25/PRNewswire/--RegadoBiosciences,aprivat...captamerswithactivecontrolagents,announcedthatDavi...perJaffray21stAnnualHealthCareConferenceattheNewYo...illbegivenat1:10pm(EST)onTuesday,December1andwilli...ontheleaddevelopmentprogram,theanticoagulantsystem...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Rights Access to Healthcare Providers of Choice at Risk 48146 1Rights Access to Healthcare Providers of Choice at Risk 48146 2Rights Access to Healthcare Providers of Choice at Risk 48146 3Metastorm Customer Wyeth Pharmaceuticals Wins CIO 100 Award for BPM Project 48143 1Metastorm Customer Wyeth Pharmaceuticals Wins CIO 100 Award for BPM Project 48143 2Yongye Biotechnology International Receives License to Manufacture Products 12507 1Yongye Biotechnology International Receives License to Manufacture Products 12507 2Yongye Biotechnology International Receives License to Manufacture Products 12507 3
...DICAL DEVICE INNOVATIONS AND SOUTHERN CALIFORNIA,S... May 12 More than 200 members of Southern Califor...nual DeviceFest on May 7th, featuring panel discus...aising options, as well as showcasing the latest i...the Fairmont Hotel was sponsored by BIOCOM, Southe...
...ed using clinical specimens confirmed , positive ...MADISON, N.J., May 11 Quest Diagnostics Incorpo... of diagnostic testing, information and services, ...ous disease reference laboratory has introduced a ...action (PCR) test to aid in identifying Influenza ...
Other Medicine Technology:BIOCOM's 4th Annual DeviceFest Honors Companies 2BIOCOM's 4th Annual DeviceFest Honors Companies 3Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus 2Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus 3Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus 4
Qwik-Let® Premier
Finnpipette Techpette Single Channel, 5-50ul
...he range from 2ul to 5000ul. Fills and empties th...advertent volume change. Novel hand grip shape re...lavable at 121C(250F). To prevent corrosion the t...-handed operation. Auto or Normal trigger mode. ...
...om Thermo Labsystems was designed specifically to .... Advanced features such as the new fast dial sys...mes help to define this as a new leader in single ...late offers a custom fit for different hand sizes....
Medicine Products: